3-hydroxyephedrine has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beanlands, RSB; Burwash, IG; Chen, SY; DaSilva, JN; deKemp, RA; Dinculescu, V; Kaps, N; Lapierre, C; Lavallee, A; Mielniczuk, LM; Miner, R; Renaud, JM; Thackeray, J; Wang, T; Wu, KY; Zelt, JGE | 1 |
| Lehikoinen, P; Malminiemi, K; Någren, K; Pietilä, M; Saraste, M; Ukkonen, H; Voipio-Pulkki, LM | 1 |
1 trial(s) available for 3-hydroxyephedrine and Chronic Illness
| Article | Year |
|---|---|
Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure.
Topics: Aged; Carbon Radioisotopes; Chronic Disease; Echocardiography; Ephedrine; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardium; Odds Ratio; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 2001 |
1 other study(ies) available for 3-hydroxyephedrine and Chronic Illness
| Article | Year |
|---|---|
Reliable quantification of myocardial sympathetic innervation and regional denervation using [
Topics: Aged; Carbon Radioisotopes; Chronic Disease; Denervation; Ephedrine; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sympathetic Nervous System | 2020 |